Alfredo Raglio, Lapo Attardo, Giulia Gontero, Silvia Rollino, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
World J Psychiatry. 2015 Mar 22;5(1):68-78. doi: 10.5498/wjp.v5.i1.68.
Mood disorder and depressive syndromes represent a common comorbid condition in neurological disorders with a prevalence rate that ranges between 20% and 50% of patients with stroke, epilepsy, multiple sclerosis, and Parkinson's disease. Notwithstanding, these conditions are often under-diagnosed and under-treated in the clinical practice and negatively affect the functional recovery, the adherence to treatment, the quality of life, and even the mortality risk. In addition, a bidirectional association between depression and neurological disorders may be possible being that depressive syndromes may be considered as a risk factor for certain neurological diseases. Despite the large amount of evidence regarding the effects of music therapy (MT) and other musical interventions on different aspects of neurological disorders, no updated article reviewing outcomes such as mood, emotions, depression, activity of daily living and so on is actually available; for this reason, little is known about the effectiveness of music and MT on these important outcomes in neurological patients. The aim of this article is to provide a narrative review of the current literature on musical interventions and their effects on mood and depression in patients with neurological disorders. Searching on PubMed and PsycInfo databases, 25 studies corresponding to the inclusion criteria have been selected; 11 of them assess the effects of music or MT in Dementia, 9 explore the efficacy on patients with Stroke, and 5 regard other neurological diseases like Multiple Sclerosis, Amyotrophic Lateral Sclerosis/motor neuron disease, Chronic quadriplegia, Parkinson's Disease, and Acquired Brain dysfunctions. Selected studies are based on relational and rehabilitative music therapy approaches or concern music listening interventions. Most of the studies support the efficacy of MT and other musical interventions on mood, depressive syndromes, and quality of life on neurological patients.
心境障碍和抑郁综合征是神经系统疾病常见的共病情况,其患病率在中风、癫痫、多发性硬化症和帕金森病患者中介于 20%至 50%之间。然而,在临床实践中,这些病症常常被漏诊和治疗不足,对功能恢复、治疗依从性、生活质量甚至死亡风险都产生负面影响。此外,抑郁和神经系统疾病之间可能存在双向关联,因为抑郁综合征可能被视为某些神经疾病的风险因素。尽管有大量关于音乐治疗(MT)和其他音乐干预对神经系统疾病不同方面的影响的证据,但实际上并没有关于评估心境、情绪、抑郁、日常生活活动等方面的结果的最新综述文章;因此,人们对音乐和 MT 在这些神经系统患者中的这些重要结果的有效性知之甚少。本文旨在对目前关于音乐干预及其对神经系统疾病患者心境和抑郁影响的文献进行叙述性综述。在 PubMed 和 PsycInfo 数据库中进行检索,共选择了 25 项符合纳入标准的研究;其中 11 项评估了音乐或 MT 在痴呆症中的效果,9 项探讨了对中风患者的疗效,5 项则涉及其他神经系统疾病,如多发性硬化症、肌萎缩性侧索硬化症/运动神经元病、慢性四肢瘫痪、帕金森病和获得性脑功能障碍。入选的研究基于关系和康复性音乐治疗方法,或涉及音乐聆听干预。大多数研究支持 MT 和其他音乐干预对神经系统疾病患者的心境、抑郁综合征和生活质量的有效性。